Immuneering Corporation (IMRX)
NGM – Real Time Price. Currency in USD
4.88
+0.08 (1.67%)
Market open: Aug 12, 2026, 11:17 AM EDT
4.71
-0.09 (-1.88%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
4.88
+0.08 (1.67%)
Market open: Aug 12, 2026, 11:17 AM EDT
4.71
-0.09 (-1.88%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $41.3M significantly exceed its total debt $3.6M, ensuring strong financial flexibility
Total current assets $158.0M exceed Total current liabilities $8.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$16.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 19.47 | 6.05 | 10 | |
| Quick ratio | 19.47 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 317K | N/A | N/A | N/A | N/A |
| Gross Profit | -638K | -764K | -713K | -699K | -625K |
| Operating Income | -52M | -58M | -64M | -59M | -63M |
| Net Income | -51M | -53M | -61M | -56M | -57M |
| EBITDA | -51M | -58M | -63M | -59M | -63M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 19.08 | 5.0 |
| Next quarter | N/A | -89.58 | 1.0 |
| Current year | N/A | 12.11 | 4.0 |
| Next year | N/A | -15.57 | 1.0 |
| Weighted average score | 2.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -28.29 | -28.56 | 10.72 | 4.8 |
| Y/Y | 999 | -19.64 | 32.5 | -74.93 | 5.5 |
| 3y average | 632.67 | -3.92 | 10.27 | -1.4 | 4.8 |
| 5y average | 360.65 | -31.83 | 13.3 | -31.98 | 5.0 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |